Cardioprotective effects of lipoic acid, quercetin and resveratrol on oxidative stress related to thyroid hormone alterations in long-term obesity

Journal of Nutritional Biochemistry

Volumn 33, Issue , 2016, Pages 36-44

  Cheserek, Maureen Jepkorir ^a,b   Wu, Guirong ^a   Li, Longnan ^a   Li, Lirong ^a,c   Karangwa, Eric ^a   Shi, Yonghui ^a   Le, Guowei ^a  

^a JIANGNAN UNIVERSITY   (China)

^b EGERTON UNIVERSITY   (Kenya)

^c KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Angiotensin converting enzyme; Antioxidants; Cardioprotection; Long term obesity; Oxidative stress; Thyroid hormones

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANGIOTENSIN II RECEPTOR TYPE 1ALPHA; ANGIOTENSIN RECEPTOR; CALCIUM ION; CATALASE; CONNEXIN 43; DEIODINASE IODOTHYRONINE TYPE 1; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYCOGEN SYNTHASE KINASE 3BETA; LIOTHYRONINE; MALONALDEHYDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; THIOCTIC ACID; THYROID HORMONE RECEPTOR ALPHA; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG; ANTIHYPERTENSIVE AGENT; ANTIOBESITY AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; CARDIOTONIC AGENT; STILBENE DERIVATIVE; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FIBROSIS; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENE EXPRESSION; GENE FUNCTION; HEART PROTECTION; ION TRANSPORT; LIOTHYRONINE BLOOD LEVEL; LIPID DIET; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PULSE RATE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; THYROTROPIN BLOOD LEVEL; UPREGULATION; WEIGHT GAIN; ANIMAL; BLOOD; C57BL MOUSE; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; DIET THERAPY; ENZYMOLOGY; GENE EXPRESSION REGULATION; HEART VENTRICLE; HYPERTENSION; HYPOTHYROIDISM; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZATION;

ANIMALS; ANTI-OBESITY AGENTS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BIOMARKERS; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; DIET, HIGH-FAT; FEMALE; GENE EXPRESSION REGULATION; HEART VENTRICLES; HYPERTENSION; HYPOTHYROIDISM; MICE, INBRED C57BL; OBESITY; OXIDATIVE STRESS; QUERCETIN; RANDOM ALLOCATION; STILBENES; THIOCTIC ACID; THYROID HORMONES; WEIGHT GAIN;

EID: 84963826955     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2016.02.008     Document Type: Article

References (53)

1. Tsutsui H., Kinugawa S., Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 2011, 301(6):H2181-H2190.
2. Savini I., Catani M.V., Evangelista D., Gasperi V., Avigliano L. Obesity-associated oxidative stress: strategies finalized to improve redox state. Int J Mol Sci 2013, 14:10497-10538.
3. Lopaschuk G.D., Folmes C.D., Stanley W.C. Cardiac energy metabolism in obesity. Circ Res 2007, 101:335-347.
4. Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol 2010, 316(2):165-171.
5. Longhi S., Radetti G. Thyroid function and obesity. J Clin Res Pediatr Endocrinol 2013, 5(Suppl. 1):40-44.
6. Xia S.F., Duan X., Hao L.Y., Chen X.R., Xie Z.X., Qiao Y., et al. Role of thyroid hormone homeostasis in obesity-prone and obesity-resistant mice fed a high-fat diet. Metabolism 2015, 64(5):566-579.
7. Santini F., Marzullo P., Rotondi M., Ceccarini G., Pagano L., Ippolito S., et al. Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. Eur J Endocrinol 2014, 171(4):R137-R152.
8. Cabanelas A., Lisboa P.C., Moura E.G., Pazos-Moura C.C. Leptin acute modulation of the 5-deiodinase activities in hypothalamus, pituitary and brown adipose tissue of fed rats. Horm Metab Res 2006, 38:481-485.
9. Zalesin K.C., Franklin B.A., Miller W.M., Peterson E.D., McCullough P.A. Impact of obesity on cardiovascular disease. Med Clin North Am 2011, 95(5):919-937.
10. Villanueva I., Alva-Sánchez C., Pacheco-Rosado J. The role of thyroid hormones as inductors of oxidative stress and neurodegeneration. Oxidative Med Cell Longev 2013, 2013:218145.
11. Mancini A., Raimondo S., Segni C.D., Persano M., Gadotti G., Silvestrini A., et al. Thyroid hormones and antioxidant systems: focus on oxidative stress in cardiovascular and pulmonary diseases. Int J Mol Sci 2013, 14:23893-23909.
12. Messarah M., Saoudi M., Boumendjel A., Boulakoud M.S., Feki A.E. Oxidative stress induced by thyroid dysfunction in rat erythrocytes and heart. Environ Toxicol Pharmacol 2011, 31(1):33-41.
13. Cheserek M.J., Wu G.R., Ntazinda A., Shi Y.H., Shen L.Y., Le G.W. Association between thyroid hormones, lipids and oxidative stress markers in subclinical hypothyroidism. J Med Biochem 2014, 33:1-9.
14. Fernández V., Tapia G., Varela P., Romanque P., Cartier-Ugarte D., Videla L.A. Thyroid hormone-induced oxidative stress in rodents and humans: a comparative view and relation to redox regulation of gene expression. Comp Biochem Physiol C Toxicol Pharmacol 2006, 142:231-239.
15. Brent G.A. Mechanisms of thyroid hormone action. J Clin Invest 2012, 122(9):3035-3043.
16. Dillmann W. Cardiac hypertrophy and thyroid hormone signaling. Heart Fail Rev 2010, 15(2):125-132.
17. Vargas F., Rodríguez-Gómez I., Vargas-Tendero P., Jimenez E., Montiel M. The renin-angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations. J Endocrinol 2012, 213:25-36.
18. Schulman I.H., Zhou M.S., Raij L. Nitric oxide, angiotensin II, and reactive oxygen species in hypertension and atherogenesis. Curr Hypertens Rep 2005, 7(1):61-67.
19. Kotsis V., Stabouli S., Papakatsika S., Rizos Z., Parati G. Mechanisms of obesity-induced hypertension. Hypertens Res 2010, 33:386-393.
20. Kong P., Christie P., Frangogiannis N.G. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 2014, 71:549-574.
21. Lijnen P.J., van Pelt J.F., Fagard R.H. Stimulation of reactive oxygen species and collagen synthesis by angiotensin II in cardiac fibroblasts. Cardiovasc Ther 2012, 30(1):e1-e8.
22. Rohilla A., Kumar P., Rohilla S., Kushnoor S. Cardiac hypertrophy: a review on pathogenesis and treatment. Int J Pharm Sci Rev Res 2012, 4(3):164-167.
23. Hasty A.H., Harrison D.G. Endoplasmic reticulum stress and hypertension - a new paradigm. J Clin Invest 2012, 122(11):3859-3861.
24. Marks A.R. Calcium cycling proteins and heart failure: mechanisms and therapeutics. J Clin Invest 2013, 123(1):46-52.
25. Tribulova N., Knezl V., Shainberg A., Seki S., Soukup T. Thyroid hormones and cardiac arrhythmias. Vasc Pharmacol 2010, 52(3-4):102-112.
26. + increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes. Circulation 2010, 121(14):1606-1613.
27. Barth A.S., Tomaselli G.F. Cardiac metabolism and arrhythmias. Circ Arrhythm Electrophysiol 2009, 2:327-335.
28. Peng T.I., Jou M.J. Oxidative stress caused by mitochondrial calcium overload. Ann N Y Acad Sci 2010, 1201:183-188.
29. Akopova O.V., Kolchynskayia L.Y., Nosaŕ V.Y., Smyrnov A.N., Malisheva M.K., Mańkovskaia Y.N., et al. The effect of permeability transition pore opening on reactive oxygen species production in rat brain mitochondria. Ukr Biokhim Zh 2011, 83(6):46-55.
30. Aoyagi T., Matsui T. Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure. Curr Pharm Des 2011, 17(18):1818-1824.
31. Nguyen T., Nioi P., Pickett C.B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 2009, 284(20):13291-13295.
32. Singh S., Vrishni S., Singh B.K., Rahman I., Kakkar P. Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radic Res 2010, 44(11):1267-1288.
33. Phukan S., Babu V.S., Kannoji A., Hariharan R., Balaji V.N. GSK3β: role in therapeutic landscape and development of modulators. Br J Pharmacol 2010, 160(1):1-19.
34. Hirotani S., Zhai P., Tomita H., Galeotti J., Marquez J.P., Gao S., et al. Inhibition of glycogen synthase kinase 3-β during heart failure is protective. Circ Res 2007, 101:1164-1174.
35. Lee J.E., Yi C., Jeon B.T., Shin H.J., Kim S.K., Jung T.S., et al. alpha-Lipoic acid attenuates cardiac fibrosis in Otsuka long-Evans Tokushima fatty rats. Cardiovasc Diabetol 2012, 11:111.
36. Han J.J., Hao J., Kim C.H., Hong J.S., Ahn H.Y., Lee Y.S. Quercetin prevents cardiac hypertrophy induced by pressure overload in rats. J Vet Med Sci 2009, 71(6):737-743.
37. Ungvari Z., Bagi Z., Feher A., Recchia F.A., Sonntag W.E., Pearson K., et al. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol 2010, 299:H18-H24.
38. Kobayashi H., Gil-Guzman E., Mahran A., Rakesh Nelson D.R., Thomas A.J., et al. Quality control of reactive oxygen species measurement by luminol-dependent chemiluminescence assay. J Androl 2001, 22:568-574.
39. Hissin P.J., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976, 74:214-226.
40. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J Biol Chem 1951, 193:265-275.
41. Myers M.G., Leibel R.L., Seeley R.J., Schwartz M.W. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab 2010, 21(11):643-651.
42. Seo E.Y., Ha A.W., Kim W.K. α-Lipoic acid reduced weight gain and improved the lipid profile in rats fed with high fat diet. Nutr Res Pract 2012, 6(3):195-200.
43. Wang Y., Li X., Guo Y., Chan L., Guan X. alpha-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice. Metabolism 2010, 59(7):967-976.
44. Baile C.A., Yang J.Y., Rayalam S., Hartzell D.L., Lai C.Y., Andersen C., et al. Effect of resveratrol on fat mobilization. Ann N Y Acad Sci 2011, 1215:40-47.
45. Moon J., Do H.J., Kim O.Y., Shin M.J. Antiobesity effects of quercetin-rich onion peel extract on the differentiation of 3T3-L1 preadipocytes and the adipogenesis in high fat-fed rats. Food Chem Toxicol 2013, 58:347-354.
46. Mishra P., Samanta L. Oxidative stress and heart failure in altered thyroid states. Sci World J 2012, 2012:741861.
47. Duntas L.H. Resveratrol and its impact on aging and thyroid function. J Endocrinol Invest 2011, 34(10):788-792.
48. de Souza Dos Santos M.C., Gonçalves C.F., Vaisman M., Ferreira A.C., de Carvalho D.P. Impact of flavonoids on thyroid function. Food Chem Toxicol 2011, 49(10):2495-2502.
49. McDonough A.A., Velotta J.B., Schwinger R.H., Philipson K.D., Farley R.A. The cardiac sodium pump: structure and function. Basic Res Cardiol 2002, 97(Suppl. 1):I19-I24.
50. Maksimenko A.V., Vavaev A.V. Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: the next stage of pharmacological counterwork to the oxidative stress. Heart Int 2012, 7(1):e3.
51. Iacopini P., Baldi M., Storchi P., Sebastiani L. Catechin, epicatechin, quercetin, rutin and resveratrol in red grape: content, in vitro antioxidant activity and interactions. J Food Compos Anal 2008, 21:589-598.
52. Suh J.H., Shenvi S.V., Dixon B.M., Liu H., Jaiswal A.K., Liu R.M., et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A 2004, 101:3381-3386.
53. Zweier J.L., Chen C.A., Druhan L.J. S-Glutathionylation reshapes our understanding of endothelial nitric oxide synthase uncoupling and nitric oxide/reactive oxygen species-mediated signaling. Antioxid Redox Signal 2011, 14(10):1769-1775.